Estados Unidos · Plataformas y datos · Yahoo Finance

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

Publicado por Yahoo Finance · Estados Unidos hace 9 h

BOSTON & SAN DIEGO, November 03, 2026--(BUSINESS WIRE)--Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

También te puede interesar

Offerpad (OPAD) Q3 2026 Earnings Call Transcript

Delta blasts a Heathrow Airport operational decision

Axa Sa (OTCMKTS:AXAHY) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

3 signs cash-strapped consumers are nearing a ‘spend-pocalypse’ that would hurt the economy

Taco Bell sales fall more than expected on cyclosporiasis outbreak hit

Best Biotech Stocks Right Now

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

Compartir

También te puede interesar

Offerpad (OPAD) Q3 2026 Earnings Call Transcript

Delta blasts a Heathrow Airport operational decision

Axa Sa (OTCMKTS:AXAHY) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

3 signs cash-strapped consumers are nearing a ‘spend-pocalypse’ that would hurt the economy

Taco Bell sales fall more than expected on cyclosporiasis outbreak hit

Best Biotech Stocks Right Now